The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis

The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis

Purpose: Women under 40 years old are at increased risk for developing human epidermal growth factor receptor 2 (HER2) positive or triple negative subtype and more advanced breast cancer, yet young age itself has also historically been an independent prognostic factor. Methods: Using the Surveillanc...

Full description

Bibliographic Details
Main Authors: Hee Jeong Kim, Seonok Kim, Rachel A. Freedman, Ann H. Partridge
Format: Article
Language:English
Published: Elsevier 2022-02-01
Series:Breast
Subjects:
Breast cancer
Young women
Age
Outcomes
Subtype
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621010122

Internet

http://www.sciencedirect.com/science/article/pii/S0960977621010122

Similar Items